Lebrikizumab (Anti-IL-13)
Product Specifications
CAS Number
953400-68-5
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Lebrikizumab (anti-IL-13) is an humanized IgG4 monoclonal antibody against interleukin 13 (IL-13) with immunosuppressive and anti-asthmatic activities. MW: 145.8 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog